For the growing number of children with type 1 diabetes, the daily burden of managing their challenging chronic disease and maintaining good blood glucose control affects every aspect of their lives ...

Type-2 diabetes is one of the most common chronic diseases in the world, characterized by high blood-sugar levels and associated with damage to blood vessels, the heart, and the nervous system.

It's not only caused by needing corrective lenses. Leading eye doctors share which conditions—big and small—can cause blurry vision.

Recent evidence reveals that more patients could benefit from receiving a continuous glucose monitoring prescription as part of diabetes care from their primary provider.

Continuous glucose monitors (CGMs) are wearable technologies that track blood sugar in real time and help patients with type 2 diabetes improve blood sugar control. In 2024, the U.S. Food and Drug ...

For me, high on that list was seeing firsthand, in real time, how the food I eat affects my blood sugar. I have a sweet tooth and a deep appreciation for carbs. This may be why my doctor has warned me ...

As per the latest market research by Business Market Insights (BMI), the research report "Pressure Monitoring Devices Market Outlook Size ...

Forbes contributors publish independent expert analyses and insights. Mark Minevich is a NY-based strategist focused on human centric AI. Inflation is a global problem, and it's one that is being ...

Mobile health apps could help improve health among older adults with diabetes, according to a study by researchers at the University of Georgia and University of Illinois Urbana-Champaign. "Even ...

This valuable study identifies a brown adipose tissue-specific heat shock factor 1-alcohol dehydrogenase 5 (ADH5) molecular cascade as a regulator of systemic aging, showing that ADH5 deficiency ...

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said in an interview.

After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold.   The ...